Pharmacy Acquisition Cost Survey Stakeholder Information Session
September 9, 2020
The Department of Health Care Services (DHCS) has contracted with Magellan Medicaid Administration (Magellan) to establish and maintain a Maximum Allowable Ingredient Cost (MAIC) program for multisource generic drug reimbursement.
The objective of the MAIC program is to establish upper limit, multisource, generic ingredient reimbursement rates that encourage efficient purchasing while being responsive to drug pricing fluctuations.
As part of the MAIC program, a MAIC survey process will begin in late September 2020. Pharmacies selected to participate in the survey will submit pharmacy invoice data directly to Magellan. The information will be used to establish MAIC reimbursement rates for multisource generic drugs, effective January 1, 2021.
A virtual stakeholder information session to review the MAIC survey process and project timeline will be held on Wednesday, September 16, at 1:00 p.m. PDT.
Please join the virtual stakeholder session by clicking on the link below:
MAIC Provider Webinar
ID: 994 4676 7475
Alternately, providers can dial in at +1-651-372-8299.
Thank you in advance for your participation in this important survey.